Chloroquine-resistant Plasmodium vivax malaria in Debre Zeit, Ethiopia

BACKGROUND: Plasmodium vivax accounts for about 40% of all malaria infection in Ethiopia. Chloroquine (CQ) is the first line treatment for confirmed P. vivax malaria in the country. The first report of CQ treatment failure in P. vivax was from Debre Zeit, which suggested the presence of chloroquine...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Teka, Hiwot, Petros, Beyene, Yamuah, Lawrence, Tesfaye, Gezahegn, Elhassan, Ibrahim, Muchohi, Simon, Kokwaro, Gilbert, Aseffa, Abraham, Engers, Howard
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2008
Schlagworte:
Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2584068/
https://ncbi.nlm.nih.gov/pubmed/18959774
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2875-7-220
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge